Literature DB >> 18545915

Treating headaches with botulinum toxin.

Marco Aguggia1.   

Abstract

Botulinum toxin type A (BT-a) has been shown to effectively treat several types of neurological disorders. For over 15 years it has been used clinically also for the prophylaxis and treatment of various types of primary headache disorders. Although BT-a efficacy has not been proven in tension-type headache, its use in migraine continues to cause controversy. There is adequate data to support the hypothesis, beside its well known effect on acetylcholine release, of an additional antinociceptive effect related to a block in the local release of nociceptive neuropeptides.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18545915     DOI： 10.1007/s10072-008-0905-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  18 in total

1.  Botulinum toxin injections for headache.

Authors:  Randolph W Evans; Andrew Blumenfeld
Journal:  Headache       Date:  2003-06       Impact factor: 5.887

2.  Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.

Authors:  Paul L Durham; Ryan Cady; Roger Cady
Journal:  Headache       Date:  2004-01       Impact factor: 5.887

3.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

4.  Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Stuart R Stark; Sylvia M Lucas; Suzanne N Christie; Ronald E Degryse; Catherine C Turkel
Journal:  Mayo Clin Proc       Date:  2005-09       Impact factor: 7.616

5.  Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors:  Ninan T Mathew; Benjamin M Frishberg; Marek Gawel; Rozalina Dimitrova; John Gibson; Catherine Turkel
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

6.  Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.

Authors:  Abigail Collins; Joseph Jankovic
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

7.  Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.

Authors:  J Purkiss; M Welch; S Doward; K Foster
Journal:  Biochem Pharmacol       Date:  2000-06-01       Impact factor: 5.858

8.  The Use of Botulinum Toxin Type A in Headache Treatment.

Authors:  Ninan T. Mathew; Alex O. Kaup
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

9.  Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.

Authors:  Wilhelm J Schulte-Mattler; Paul Krack
Journal:  Pain       Date:  2004-05       Impact factor: 6.961

10.  Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.

Authors:  Stewart J Tepper; Marcelo E Bigal; Fred D Sheftell; Alan M Rapoport
Journal:  Headache       Date:  2004-09       Impact factor: 5.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.